Two candidate gene polymorphisms in ADHD children: A case-control study of catechol-O-methyltransferase (COMT) and monoamine oxidase B (MAOB) genes

Archives of Medical Science

Volumn 2, Issue 4, 2006, Pages 235-239

  Staif, Radim ^a   Drtilkova, Ivana ^a   Theiner, Pavel ^a   Didden, William ^b   Pitelova, Renata ^a   Mikes, Vladimir ^a   Sery, Omar ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b GHC Research Institute   (United States)

Author keywords

ADHD; COMT; Gene; MAOB; Polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BIOGENIC AMINE; CATECHOL METHYLTRANSFERASE; METHIONINE; MONOAMINE OXIDASE INHIBITOR; NEUROTRANSMITTER; VALINE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME METABOLISM; FISHER EXACT TEST; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SCHOOL CHILD;

EID: 33846306758     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Szatmari P, Offord DR, Boyle MH. Ontario child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry 1989; 30: 219-30.
2. Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002; 6 (Suppl 1): S7-16.
3. di Michele F, Prichep L, John ER, Chabot RJ. The neurophysiology of attention-deficit/hyperactivity disorder. Int J Psychophysiol 2005; 58: 81-93.
4. Gunay Kilic B. Neuropsychology of attention deficit hyperactivity disorder: relevant theories and empirical studies. Turk Psikiyatri Derg 2005; 16: 113-23.
5. Kauhanen J, Hallikainen T, Tuomainen TP, Koulu M, Karvonen MK, Salonen JT, et al. Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res 2000; 24: 135-9.
6. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 1998; 155: 835-7.
7. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 841-5.
8. Brunner HG, Helen MR, van Zandvoort P, Abeling NG, van Gennip AH, et al. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet 1993; 52: 1032-9.
9. Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, et al. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol 2002; 442: 331-47.
10. Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O. Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J Comp Neurol 2003; 464: 392-403.
11. Hashizume C, Suzuki M, Masuda K, Momozawa Y, Kikusui T, Takeuchi Y, et al. Molecular cloning of canine monoamine oxidase subtypes A (MAOA) and B (MAOB) cDNAs and their expression in the brain. J Vet Med Sci 2003; 65: 893-8.
12. Ikemoto K, Kitahama K, Maeda T, Tokunaga Y, Valatx JL, De Maeyer E, et al. Electron-microscopic study of MAOB-containing structures in the nucleus accumbens shell: using MAOA-deficient transgenic mice. Brain Res 1997; 771: 163-6.
13. Oreland L, Damberg M, Hallman J, Berggard C, Garpenstrand H. Risk factors for the neurohumoral alterations underlying personality disturbances. Neurotox Res 2002; 4: 421-6.
14. Garpenstrand H, Norton N, Damberg M, Rylander G, Forslund K, Mattila-Evenden M, et al. A regulatory monoamine oxidase a promoter polymorphism and personality traits. Neuropsychobiology 2002; 46: 190-3.
15. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 1990; 47: 391-417.
16. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm 2000; 107: 523-30.
17. Mynett-Johnson LA, Murphz VE, Claffey E, Shields DC, McKeon P. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 1998; 8: 221-5.
18. Rogeness GA, Hernandez JM, Macedo CA, Mitchell EL. Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 1982; 139: 307-11.
19. Kuperman S, Kramer J, Loney J. Enzyme activity and behavior in hyperactive children grown up. Biol Psychiatry 1988; 24: 375-83.
20. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet 1999; 88: 497-502.
21. Reuter M, Kirsch P, Hennig J. Inferring candidate genes for Attention Deficit Hyperactivity Disorder (ADHD) assessed by the World Health Organization Adult ADHD Self-Report Scale (ASRS). J. Neurol Transm 2006; 113: 929-38.
22. Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, Robertson IH, et al. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD. Exp Brain Res 2005; 163: 352-60.
23. Sery O, Didden W, Mikes V, Pitelova R, Znojil V, Zvolsky P. The association between high-activity COMT allele and alcoholism. Neuroendocrinology Letters 2006; 27: 231-5.
24. Barr CL, Wigg K, Malone M, Schachar R, Tannock R, Roberts W, et al. Linkage study of catechol-O-methyltransferase and attention-deficit hyperactivity disorder. Am J Med Genet 1999; 88: 710-3.
25. Hawi Z, Millar N, Daly G, Fitzgerald M, Gill M. No association between catechol-O-methyltransferase (COMT) gene polymorphism and attention deficit hyperactivity disorder (ADHD) in an Irish sample. Am J Med Genet 2000; 96: 282-4.
26. Tahir E, Curran S, Yazgan Y, Ozbay F, Cirakoglu B, Asherson PJ. No association between low- and high-activity catecholamine-methyl-transferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Am J Med Genet 2000; 96: 285-58.
27. Payton A, Holmes J, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, et al. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study. Am J Med Genet 2001; 105: 464-70.
28. Zhang XN, Ruan LM, Le YP, Zhang Y. Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003; 204: 322-4.
29. Mills S, Langley K, Van den Bree M, Street E, Turic D, Owen MJ, et al. No evidence of association between Catechol-O-Methyltransferase (COMT) Val158Met genotype and performance on neuropsychological tasks in children with ADHD: a case-control study. BMC Psychiatry 2004; 4: 15.
30. Taerk E, Grizenko N, Ben Amor L, Lageix P, Mbekou V, Deguzman R, et al. Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet 2004; 5: 30.
31. Turic D, Williams H, Langley K, Owen M, Thapar A, O'Donovan MC. A family based study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 2005; 133: 64-7.
32. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 67-72.
33. Jiang S, Xin R, Lin S, Qian Y, Tang G, Wang D. Linkage studies between attention-deficit hyperactivity disorder and the monoamine oxidase genes. Am J Med Genet 2001; 105: 783-8.
34. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, et al. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 110-4.
35. Sery O, Hradilova O, Didden W, Klenerova V, Staif R, Znojil V, Sevcik P. The association of monoamine oxidase B functional polymorphism with postoperative pain intensity. Neuro Endocrinol Lett 2006; 27: 333-7.